BDBM796577 (17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-hexahydro-8H-3,5- ethenotripyrazolo[3,4-f:3'',4''-j:4$#8243;,3$#8243;- n][1,4]oxazacyclopentadecine-16- carbonitrile::US20260070924, Example 24

SMILES CN1CCOc2c(cnn2C)-c2ccc3[nH]nc(c3c2)/C=C/c2c(C#N)cn(C)c2C1=O

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 796577   

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796577BDBM796577((17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-h...)
Affinity DataIC50: 0.230nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDual specificity protein kinase CLK1(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796577BDBM796577((17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-h...)
Affinity DataIC50: 0.415nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796577BDBM796577((17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-h...)
Affinity DataIC50: 0.475nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDual specificity protein kinase CLK4(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796577BDBM796577((17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-h...)
Affinity DataIC50: 0.593nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDual specificity protein kinase CLK2(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796577BDBM796577((17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-h...)
Affinity DataIC50: 0.670nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDual specificity protein kinase CLK3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796577BDBM796577((17E)-8,12,14-trimethyl-13-oxo- 2,10,11,12,13,14-h...)
Affinity DataIC50: 92.9nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent